Veraxa Biotech Holding AG Ratios (2024-2025) | VRXA

Ratios Dec2024 Dec2025
Efficiency
Assets Average (Quarter) 98.94M
Leverage & Solvency
Debt Ratio (Quarter) 0.020.04
Valuation
Enterprise Value (Quarter) -6.30M-1.52M